• Search
  • Advanced Search
Korean J Hepatol > Volume 14(3); 2008 > Article
7
The Korean Journal of Hepatology 2008;14(3): 411-416.
doi: https://doi.org/10.3350/kjhep.2008.14.3.411
The Korean Journal of Entecavir 1 mg therapy for Lamivudine-refractory chronic hepatitis B
Hyung Joon Kim
Department of Internal Medicine, Chung-Ang University School of Medicine, Seoul, Korea
KeyWords: Lamivudine resistance; Entecavir; Hepatitis B, Chronic
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 4,263 View
  • 17 Download
Related articles

The use of transient elastography for predicting hepatocellular carcinoma in chronic hepatitis B patients

The role of different viral biomarkers on the management of chronic hepatitis B2023 April;29(2)

Emerging medical therapies for severe alcoholic hepatitis2020 October;26(4)

New perspectives of biomarkers for the management of chronic hepatitis B2016 December;22(4)

Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?2016 June;22(2)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 893
TOTAL : 2094339
Close layer